Despite cellular models supporting the toxic role of Rhes, its desired pharmacology in HD remains unclear since prior studies in HD rodent models report both protective and detrimental effects of Rhes on HD-like behavioral and anatomical deficits [9,10,25–28]. This evidence concerns the gene RASD2 and Huntington disease.